Minute Insight: Ondine Biomedical Debuts Phase 2 Preliminary Data Demonstrating Power Of Photodisinfection

Ondine Biomedical’s method of disinfection is easy to administer, cheap, and does not promote antimicrobial resistance.

Minute Insight
• Source: Informa/Alamy

Ondine Biomedical has released preliminary data from the BENEFIT PDT phase two study of its Steriwave nasal photodisinfection tool.

Results from 319 patients showed that 92% of patients exhibited a significant reduction in staphylococcus aureus population after five minutes...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D